• Home
  • About Us
    • Meet Our Team
    • Vision, Mission and Core Values
    • Trusted Partners
    • Giving Back
    • In the News
    • Careers
  • For Patients
    • Study Opportunities
    • Clinical Trial Opportunities
    • Sign Up to Participate
    • Types of Research
    • Find Us in the Community
    • Frequently Asked Questions
    • How We Use Your Information
    • Newsletters
  • For Advocacy Groups
  • For Researchers
    • Patient/Caregiver Panels
    • Pricing
    • Proposal Requests
    • Frequently Asked Questions
    • Industry Conferences
    • Diseases
      • Hemophilia
      • Multiple Sclerosis
      • Breast Cancer
      • Diabetes
      • Multiple Myeloma
      • Epilepsy
      • Non-Small Cell Lung Cancer
      • HIV
  • Blog
    • Patient Blog
    • Business Blog
  • Sign In
  • Case Studies
    • The Long and Winding Road to Care
    • Health Literacy Initiative’s PSA
    • Patient Perspectives on Clinical Trial Participation
    • Patient Journeys and Insights for Oncology and Rare Diseases
    • Market Access: A Patient Perspective
    • The Impact of Rare Diseases on Patients and Caregivers
    • The Role of Patient Advocacy Groups
    • Zebras Do Exist: The Diagnostic Odyssey of Rare Disease Patients
    • Patient Insights on Telehealth: A Case Study
    • Hearing is Believing: Reducing Barriers to Amplify the Patient Voice

Rare Patient Voice

Helping Patients with Rare Diseases Voice Their Opinions

  • Home
  • About Us
    • Meet Our Team
    • Vision, Mission and Core Values
    • Trusted Partners
    • Giving Back
    • In the News
    • Careers
  • For Patients
    • Study Opportunities
    • Clinical Trial Opportunities
    • Sign Up to Participate
    • Types of Research
    • Find Us in the Community
    • Frequently Asked Questions
    • How We Use Your Information
    • Newsletters
  • For Advocacy Groups
  • For Researchers
    • Patient/Caregiver Panels
    • Pricing
    • Proposal Requests
    • Frequently Asked Questions
    • Industry Conferences
    • Diseases
      • Hemophilia
      • Multiple Sclerosis
      • Breast Cancer
      • Diabetes
      • Multiple Myeloma
      • Epilepsy
      • Non-Small Cell Lung Cancer
      • HIV
  • Blog
    • Patient Blog
    • Business Blog
  • Sign In
  • Case Studies
    • The Long and Winding Road to Care
    • Health Literacy Initiative’s PSA
    • Patient Perspectives on Clinical Trial Participation
    • Patient Journeys and Insights for Oncology and Rare Diseases
    • Market Access: A Patient Perspective
    • The Impact of Rare Diseases on Patients and Caregivers
    • The Role of Patient Advocacy Groups
    • Zebras Do Exist: The Diagnostic Odyssey of Rare Disease Patients
    • Patient Insights on Telehealth: A Case Study
    • Hearing is Believing: Reducing Barriers to Amplify the Patient Voice

Helping patients and caregivers share their voices

Newsletter #34 – March 16, 2022

Rare Patient Voice Newsletter

What's New at Rare Patient Voice?

Study Results

Recently, Rare Patient Voice partnered with MediFind, an advanced digital health platform helping people facing complex health challenges find care, and surveyed 1,229 members of the RPV community on the current journey to diagnosis and care. The resulting report, "The Long and Winding Road to Care'' which can be downloaded here, shows progress being made for patients, but unevenly across disease types and other demographics. Key takeaways include:

The diagnostic journey continues to vary

  • Patients with rare diseases took longer to be correctly diagnosed: only 23% were diagnosed within three months, while it took five or more years for 28% of patients. For patients with cancer, two-thirds were diagnosed within three months, and only 1% took five or more years to be properly diagnosed.
  • On average, patients report seeing four different doctors before getting correctly diagnosed. This number jumps to almost six different doctors when the patient has a rare disease.

Genetic testing is shortening time-to-diagnosis, but progress is uneven

  • Genetic testing has become particularly prevalent for patients with cancer as 75% of patients diagnosed with cancer over the last two years have been genetically tested.
  • Surprisingly, genetic testing is not a mainstay of rare disease diagnosis, with only 20% of patients diagnosed with a rare disease in the past two years reporting that they received genetic testing.

Clinical expertise drives specialist choice

  • 55% of rare disease patients say clinical expertise is the most important factor when choosing their doctor, as opposed to 47% of complex disease patients.
  • 88% of primary care doctors say medical skill is of great importance when selecting to whom they will refer patients, although how doctors practically evaluate such skill remains unclear.

Record a Video, Receive Rarity!

Help us spread the word to other patients and caregivers about RPV by submitting a short video on your experience with us. Check out the growing group of patients and caregivers who have recorded stories: https://rarepatientvoice.com#sharevoice. As a thank you for recording a video, we will send you a Rarity zebra plushie AND enter you in a raffle to win a $100 Amazon gift card.

Follow these steps to record and submit your own video!

Step 1: Scan with code below with the camera app from your Apple/Android mobile device or click the link below!

https://admin.storyvine.com/app_users/sign_up/Sharing_My_Voice

Step 2: Download the Storyvine app from the App Store or Google Play

Step 3: Film and upload your video!

New on the Bookshelf

Partner Corner

LUNGevity Foundation is the nation’s leading lung cancer organization focused on improving outcomes for people with lung cancer through research, education, policy initiatives, and support and engagement for patients, survivors, and caregivers. LUNGevity seeks to make an immediate impact on quality of life and survivorship for everyone touched by the disease—while promoting health equity by addressing disparities throughout the care continuum. LUNGevity works tirelessly to advance research into early detection and more effective treatments, provide information and educational tools to empower patients and their caregivers, promote impactful public policy initiatives, and amplify the patient voice through research and engagement. The organization provides an active community for patients and survivors—and those who help them live longer and better lives.

One of the foundation’s activities to amplify the patient voice is project PEER: Understanding the lung cancer Patient ExperiEnce in the Real-world setting. PEER is an international study, open to any adult participant with lung cancer or caregiver who can read and respond to questions in English. Individuals must be 18 years of age or older and can access and use a device with a web browser that connects to the internet.

Via online surveys, we ask questions about your background, overall health, lung cancer diagnosis, treatment history, treatment satisfaction, physical well-being, and emotional quality of life. You would be asked to complete, at sign up, an initial longer survey (30-40 minutes) and then short (7-12 minute) monthly surveys for one year. You will be compensated for your time.

Why does Project PEER want my data?
Patient-reported data is a powerful source of real-world data. It can complement clinician-reported data and electronic health records data to identify treatment patterns. This is important because

  1. Only 3%-5% patients participate in clinical trials, so reliance on clinical trials as the only source of patient experience is incomplete
  2. Clinical trials exclude real-world patients with brain metastasis, prior cancers, and poor performance status
  3. Patients in the real world undergo treatment based on non-clinical factors such as access and availability

To join PEER visit www.studylc2.empiramed.org or email ProjectPEER@lungevity.org if questions. To learn more about LUNGevity Foundation visit www.LUNGevity.org.

Referrals?

Would you like to refer others to participate in research? You will receive $10 for everyone who signs up through your link! Become a Referral Partner

Current Study Opportunities

We have hundreds of studies open for patients and caregivers! Some of the studies we are working to fill immediately are listed below.

  1. If you are already a member of Rare Patient Voice and want to be considered for a study listed below, please contact study.inquiries@rarepatientvoice.com.
  2. If you are NOT a member, please click here to complete the sign-up process and include all medical conditions to be considered for one or more of the studies below and any other relevant studies.

Please feel free to share this page with friends or family who might be interested!

United States

Bladder Cancer – Non Muscle Invasive Bladder Cancer patients and caregivers United States AFS_6548 60-min web-assisted phone interview compensation is $175

Spinal Muscular Atrophy patients United States ZS_6227 60-min web-assisted phone interview compensation is $100

Alzheimer’s Disease or Dementia - patients and caregivers living in Philadelphia, PA or Evanston, IL United States DS_6542 In-person interviews consisting of solo patient, solo caregiver, and/or combined patient and caregiver sessions. Participants will be paid, the Project Manager has payment details.

Autosomal Dominant Polycystic Kidney Disease (ADPKD) patients United States IPS_6513 Multiple phases in the study that consist of web-assisted phone interviews, compensation is based on participation and is up to $1205

Urinary Tract Infection (UTI) patients United States PHARV_6554 60-min web-assisted phone interview compensation is $100

Non-Small Cell Lung Cancer - male patients United States IPS_6519 60-min web-assisted phone interview compensation is $100

Breast Cancer patients United States ZS_6522 60-min online forum compensation is $100

We are looking for patients from the Chicago area that are on the following Medications: Aimovig, Repatha, or Enbrel United States FW_6520 60-min in-person study compensation is $150

Non Small Cell Lung Cancer (NSCLC) patient United States LAG_6511 60 min web-cam interview compensation is $200

Hepatitis B patients and caregivers United States INV_6525 20-min online survey (to be taken from a phone as there is a portion that includes voice response) compensation is $35

Hemophilia B patients United States PUT_6420 20-min online survey compensation is $35

Non Small Cell Lung Cancer (NSCLC) patients United States LAG_6511 60-min webcam interview (plus homework) compensation is $200

Chronic Heart Failure & Congestive Heart Failure caregivers of patients that are age 1-17 years United States XYZ_6526 60-min web-assisted phone interview compensation is $100

Clinically Isolated Syndrome (CIS), or Relapse-Remitting (RRMS), or Secondary Progressive MS (SPMS) patients United States DYN_6440 35-min online survey compensation is $60

WHIM Syndrome patients and caregivers United States RMR_6517 60-min web assisted phone interview compensation is $100

Paroxysmal Nocturnal Hemoglobinuria patients and caregivers United States TRI_6197 60-min web assisted phone interview compensation is $100

Sjogren's Syndrome patients United States KPD_6441 40-min online survey compensation is $85

Ankylosing Spondylitis - Male Patients United States GP_6502 45-min web assisted phone interview (physician confirmation of diagnosis is required in order qualify and to be paid) compensation is $135

Multiple Myeloma patients United States GP_6473 90-min web assisted phone interview (or two 45 min interviews if the patient prefers) compensation is $210

Psoriasis patients United States GP_6305 30-min online survey compensation is $50

Glioblastoma patients/caregiver pairs United States ELR_6454 60 min joint web-assisted phone interview, plus 2-3 pre-work activities and the compensation is $600 for a patient/caregiver pair ($500 for the patient, $100 for the caregiver as the caregiver is meant to assist the patient for the interview and activities).

Psoriasis or Psoriatic Arthritis patients United States HOR_6504 90-min web-assisted phone interview and the compensation is $225

Non-Hodgkin Lymphoma Patients with Caregivers United States WORK_6478 10-min online survey, plus 30-min pre-call phone interview, plus 60-minute web-assisted phone interview (up to 6 sessions of the interview) and the compensation is $20 survey, $50 Pre-call, $100 per session of the web-assisted phone interview

Hemophilia A study for Patients and Caregivers living in Dallas, LA, or Chicago United States SCH_6385 In-person Interview (length and compensated vary)

Burkitt Lymphoma or B-Cell Lymphoma Patients United States RP_6484 2 min survey no reward

Parkinson's Disease Patients United States PDIE_6401 60-min web-assisted phone interview compensation is $100

Diffuse Large B-Cell Lymphoma (DLBCL) Patients and Caregivers United States CHP_6501 60-min web-assisted phone interview compensation is $100

Eosinophilic Esophagitis (EoE) - male patients United States TRI_6405 60-min web-assisted phone interview compensation is $100

Multiple Sclerosis relapsing-remitting patients United States KPD_6396 30 min online survey and compensation is $50

Psoriatic Arthritis or Hidradenitis Suppurativa caregivers United States BV_6402 60-min web-assisted phone interview and the compensation is $125

High Blood Pressure male patients United States GP_6043_W2 If chosen for the study, the length of time commitment is 30-mins for an online survey and the compensation is $50 + $25 COD (if chosen)

Myasthenia Gravis patients United States HEU_6410 30-min online survey and compensation is $50

Colorectal, Colon, Bowel or Rectal Cancer patients United States GP_6409 60-min web-assisted phone interview and the compensation is $150

Hemophilia Patients and Caregivers United States REAC_6423 5-min online survey with no compensation for the survey (some participants may be selected for an in person study

Bronchiectasis patients United States MP_6398 60-min and compensation is $100

Neuromyelitis optica spectrum disorder (NMOSD) and NMO Patients United States ZS_6399 10 min Online Survey and Compensation is $40

Thyroid Eye Disease (TED) MALE Patients United States 21G_6335 Year-long study (consists of 4 web-assisted phone interviews), payment upon completion of tasks

Multiple Myeloma Patients and Caregivers ZS_6399 25-min Online Survey and Compensation is $45

Chronic Kidney Disease (CKD) Patients United States 35 min Online Survey and Compensation is $45

Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis Patients United States EVR_6306 15 min Online Survey and Compensation is $20

End Stage Renal Disease Patients United States OSG_6206 60 min Zoom Interview and Compensation is $100

Myotonic Muscular Dystrophy Patients and Caregivers United States MP_6339 60 min Web-Assisted Phone Interview and Compensation is $100

Pompe Disease  United States PICH_5652 5 min Online Survey for Medical History Platform and Compensation is $20

Multiple Sclerosis (MS)  United States PICH_4373_W2 5 min Online Survey for Medical History Platform and Compensation is $25

Paroxysmal Nocturnal Hemoglobinuria (PNH) United States PICH_4376 5 min Online Survey for Medical History Platform and Compensation is $250

Uterine Fibroids United States IPS_6179 60 min Web-Assisted Phone Interview and Compensation is $100

Stasis Dermatitis United States TRP_6194 60 min Web-Assisted Phone Interview and Compensation is $135

Organ Transplant Patients United States AV_5244 60 min Phone Interview and Compensation is $120

Huntington Disease or Tardive Dyskinesia Patients  United States M3_5317 75 min Phone Interview and Compensation is $125

Psoriatic Arthritis, Rheumatoid Arthritis, or Ulcerative Colitis Patients United States PHO_2397 30 min Online Survey and Compensation is $50

Wilson's Disease Patients United States PICH_5656 5 min Online Survey and Compensation is $25 gift card

Vulvar HSIL Patients  United States RTI_5017 30 min Online Survey and Compensation is $100

Glioblastoma Caregivers of patients ages 1-17  United States TIS_6016 60 min Web-Assisted Interview and Compensation is $100

Bladder Cancer Patients  United States 60 min Web-Assisted Interview and Compensation is $100

Spina Bifida Patients and Caregivers United States M3_6079 60 min Web-Assisted Interview and Compensation is $100

Milk Allergy (not lactose intolerance)-HIV, Organ/Bone Marrow Transplants- Cancer treatment or taking a Cancer medication Patients United States QMMR_5201 60 min Phone Interview and Compensation is $100

Amyotrophic Lateral Sclerosis (ALS) Patients and Caregivers  United States PICH_5650 5-10 min Online Survey and Compensation is $25

Alzheimer's Disease Patients United States PICH_5649 5-10 min Online Survey and Compensation is $25

United States Clinical Trials:

Respiratory Syncytial Virus (RSV) patientsUnited States IFMA_6453 The total length of participation in this clinical trial is approximately 2 years (25 months). It includes up to 8 trial visits and 26 brief communications (via telephone, email, or text message) participants will be compensated for their time

Restless Leg Syndrome United States IFMA_6307 24 week long Clinical Trial and Compensation will be discussed with those that are selected to participate

Cytomegalovirus (CMV) United States IFMA_6311 18-month long Clinical Trial and Compensation will be discussed with those that are selected to participate.

Canada

Organ Transplant, Blood Cancer, or Cytomegalovirus (CMV) patients and caregivers Canada HUM_6445 90-min web-assisted phone interview (plus a 30-min homework assignment) compensation is 220 CAD

Colorectal, Colon, Bowel or Rectal Cancer patients Canada GP_6409 60-min web-assisted phone interview and the compensation is 190 CAD

Organ Transplant Patients Canada AV_5244 60 min Phone Interview and Compensation is 80 CAD

Frequently Asked Questions

Why sign up with Rare Patient Voice?
Who knows better than you about your journey and experiences? We connect you with researchers who are developing products and services which can help you and others with your condition. These researchers need patient input so that they develop products and services that have a meaningful impact on patients’ lives.

How will I be paid?
You will earn $100 per hour for participating in studies. We pay by check to ensure patients can use their compensation in any way they wish.

About Rare Patient Voice
Rare Patient Voice connects patients and caregivers with researchers who are developing products and services to help you and others with your condition. RPV has paid patients over $8 million dollars since 2013 for participating in research studies.

To read more newsletters, click here.

Latest Blog Posts

  • Real & Rare with Sarah: The Stages of Life with a Rare Disease
  • Weekly Warrior: Meet Rachel
  • The Rare Disorder Podcast interviews RPV’s Wes Michael
  • Weekly Warrior: Meet Sam
  • Real & Rare with Sarah: Make Time for You

Check Out Our YouTube Channel!

https://youtu.be/cfjkqh5Ykp0
HTML tutorial

Read Our Newsletter

Read our Newsletter
What’s New at Rare Patient Voice?

Rare Patient Voice

711 Hampton Lane
Towson, Maryland 21286
ContactUs@RarePatientVoice.com
(443) 986-1949


Visit our international site, rarepatientvoice.global


Careers


For Patients

  • Learn about us
  • Vision, Mission and Core Values
  • Sign up to participate
  • Find us in the community
  • Read our blog for patients
  • Privacy Policy

For Related Groups

  • Are you an advocacy group for a rare disease?
  • Are you a researcher?
  • Read our blog for businesses

   Instagram

     

Rare Patient Voice, LLC, Market Research, Towson, MD

©2022. Rare Patient Voice. All Rights
Reserved. Privacy Policy. Disclaimers. Sitemap

©2022 . All Rights Reserved.

Copyright © 2022 · Genesis Framework · WordPress · Log in

Search Our Website

We use cookies to ensure the best experience with Rare Patient Voice. By clicking “Accept”, you agree to our privacy policy.
Privacy Policy   |    Cookies    |    Accept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT